-+ 0.00%
-+ 0.00%
-+ 0.00%

Tempest Therapeutics Outlines Future Plans to Advance Dual-Targeting CAR-T Programs, Expand In Vivo Pipeline, and Pursue Partner-Funded Development Strategies

Reuters·02/11/2026 11:59:29

Please log in to view news